CD274 and cancer: ,38 Another possible explanation for the poor response rates to immunotherapy in SCLC may be that PD-L1 expression is much lower in SCLC compared to other solid tumors, and cancer cell PD-L1 expression seemingly does not correlate with ICI efficacy.34